Savvy Trades and Investments

[rado]

I did not grab any on the dip. I was expecting a larger pop on top line growth thinking it deserved a higher PE on the NASDAQ. They only recently moved to the NASDAQ. And I thought there would still be some mutual funds buying who could not buy before, but maybe they wanted to see continued growth which was there. They will have a tougher time increasing on earnings now that their NOLs are completely out. But they still have easy predictable growth for a few years taking the market share from the big player that left the market. And they are trying to get FDA and CE marking approval on their blood volume monitor. Also their orders have been growing at 30% and this quarter that increased to 35% with their aggressive sales person growth. Q1 weaker because of unmet deductibles at the beginning of the year and doctor vacations, so I guess near-term expectations won't be that high.